Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 15:53 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | TX | 60 beds | Grade D | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 453053 | BOWIE, TX | 60 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 60-bed community hospital in BOWIE, TX with $15.2M in net patient revenue and a 6.1% operating margin. The hospital serves a payer mix of 70.9% Medicare, 0.0% Medicaid, and 29.1% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.1% to 13.4% (+736bps).

Net Revenue HCRIS$15.2M
Current EBITDA COMPUTED$921K
Operating Margin COMPUTED6.1%
Occupancy HCRIS68.5%
Revenue / Bed COMPUTED$254K
Net-to-Gross HCRIS67.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
231
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 6.1% places it above the state median. Among 231 size-comparable peers (30-120 beds), the median margin is -0.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-120), prioritizing same-state peers. 231 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)TX60$15.2M6.1%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
PRESBYTERIAN HOSP FLOWER MOUNDTX99$215.0M28.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$319K+210bp18mo
Cost to Collect4.5%2.5%$304K+200bp12mo
Denial Rate Reduction12.0%6.5%$301K+198bp12mo
A/R Days Reduction5200.0%3800.0%$185K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$319K
Cost to Collect
$304K
Denial Rate Reduction
$301K
A/R Days Reduction
$185K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$921K
+ RCM Uplift+$1.1M
Pro Forma EBITDA$2.0M
Current Margin6.1%
Pro Forma Margin13.4%
WC Released (1x)$583K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.4M$17.3M12.19x64.9%
Base (11x exit)10.0x11.0x$1.4M$19.5M13.74x68.9%
Bull Case9.0x11.0x$1.3M$23.6M18.52x79.3%
Bull (12x exit)9.0x12.0x$1.3M$26.1M20.50x83.0%
Bear Case11.0x10.0x$1.6M$11.2M7.20x48.4%
Bear (11x exit)11.0x11.0x$1.6M$12.8M8.24x52.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 70.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 231 hospitals with 30-120 beds
  • Same-state prioritization (n=232)
  • Comp margins: P25=-14.4% / P50=-0.2% / P75=11.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.